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Abstract
Background: Epithelioid angiomyolipoma is defined as potentially malignant mesenchymal neoplasm, characterized by
proliferating epithelioid cells, whereas classic angiomyolipoma, composed of fat, smooth muscle cells and dysmorphic
vessels, is defined as a potentially benign. The usual or classic angiomyolipoma is often found incidentally on imaging
studies, relatively easily identified due to the presence of fat, in contrast to the epithelioid angiomyolipoma that can pose
diagnostic challenges.
Case presentation: We report a 51-year-old female patient in which an ultrasonography examination showed a solid
mass close to the right renal pelvis with hypoechoic and hyperechoic areas. A differential diagnosis of atypical sinus
lipomatosis, lipoma and a transitional cell carcinoma was postulated whereas in a subsequent computed tomography a
classic angiomyolipoma was postulated. A re-examination by contrast enhanced ultrasound revealed a striking perfusion
difference of the hypoechoic and hyperechoic areas. The hypoechoic area showed homogenous and
prolonged enhancement whereas the hypoechoic area displayed a marked slower contrast material
flooding and a relatively rapid wash out. The histological analysis from the biopsy of the hyperechoic
area showed a classic angiomyolipoma, whereas the sample of the hypoechoic central portion revealed
an epithelioid angiomyolipoma. A nephrectomy was performed because of the malignant potential of the
epithelioid variant of the angiomyolipoma.
Conclusions: A solid kidney mass with two sharply defined parts, one-part compatible with a classical
angiomyolipoma and the other being suspected of carcinoma, is rare, but also illustrative and instructive.
The combination of different imaging modalities in the work up of a solid renal mass facilitated to
discriminate benign from malignant areas.
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Background
Epithelioid angiomyolipoma is defined as a potentially
malignant mesenchymal neoplasm, characterized by pro-
liferating epithelioid cells, whereas classic angiomyoli-
poma, composed of fat, smooth muscle cells and
dysmorphic vessels, is considered benign [1]. Classic kid-
ney angiomyolipoma appears in 0.3% of the general
population and accounts for 3% of solid renal masses
whereas epithelioid angiomyolipoma is very rare. Classic
angiomyolipoma and epithelioid angiomyolipoma have
been associated with tuberous sclerosis [2, 3].The usual
or classic angiomyolipoma is often found incidentally on
imaging studies, relatively easily identified due to the
presence of fat, in contrast to the epithelioid angiomyoli-
poma that can pose diagnostic challenges as it mimics a
large variety of neoplasms.
Ultrasound contrast agent consist of gas microbubbles
enclosed in lipid shells. These microspheres are about
the half size of a red blood cell and remain only intravas-
cular and thus do not cross into the interstitial space
whereas most computed tomography and magnetic res-
onance imaging agents cross the vessels [4]. Ultrasound
contrast agent therefore is not excreted in the collecting
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system of the kidney facilitating the quantification of
tumor perfusion by analyzing tumor vascular enhancement
patterns [5]. Contrast-enhanced ultrasound allows to con-
tinuously acquire images creating a time-intensity curve as
compared with magnetic resonance imaging or computed
tomography with limited number of time points [6]. Fur-
thermore, ultrasound contrast agents can be administrated
multiple times for repeated acquisitions and exhibit no risk
for nephrotoxicity, cerebral deposition or nephrogenic sys-
temic fibrosis and lacks radiation burden.
On conventional B-mode ultrasound, classical renal
angiomyolipoma most commonly present as a uniform
hyperechoic lesion due to the presence of fat. The assess-
ment of hyperechoic renal mass with computer tomog-
raphy or magnetic resonance imaging can aid in diagnosing
angiomyolipoma: negative attenuation on computer tomog-
raphy and signal dropping on fat-suppressed magnetic res-
onance sequences are findings which refer to an
angiomyolipoma. Applying contrast-enhanced ultrasound,
renal angiomyolipomas are characterized by homogenous
enhancement and a prolonged enhancement time during
the corticomedullary and late phase. Xu et al. demonstrated
that an early washout, a heterogeneous enhancement, and
the presence of a peritumoral rim are lesions suspect for
renal cell carcinoma. [7]
The evaluation of the dignity of solid renal masses on
imaging is often challenging. Computer tomography,
magnetic resonance imaging and ultrasound can often
not accurately distinguish between benign and malignant
renal masses [8, 9] whereas the combination of various
examination techniques can complete each other in the
work up of a patient with a renal mass.
Case presentation
A 52-year-old female patient with recurrent urinary tract
infections underwent abdominal ultrasound examination.
The right kidney ultrasound showed a sharply restricted,
hypoechoic solid renal mass of 2.5 cm diameter without
posterior acoustic shadowing closely located to the renal
sinus. The kidney was not congested. Atypical sinus lipo-
matosis, lipomas or a transitional cell carcinoma was sus-
pected and subsequently a computer tomography scan
was performed showing a homogenous mass that met the
criteria for a classic angiomyolipoma (Fig. 1). A computed
tomography scan repeated 2 years later demonstrated a
possible tumor growth to 3 cm in diameters. Another 2
years later, an ultrasound examination revealed two differ-
ent areas of the solid mass: a hyperechoic outer rim (echo-
genicity tumor to normal kidney cortex ratio (TQ) of
2.27) and inner hypoechoic portion (TQ of 0.47.) as dis-
played in Fig. 2a. Echogenicity was measured according to
prior reported method [10–12]. A contrast enhanced
ultrasound was performed displaying a distinct different
perfusion pattern of these two areas. In the hyperechoic
peripheral area, we noticed a strong perfusion that started
nearly simultaneously with the renal cortex and a marked
slower contrast material flooding with a relatively rapid
wash out in the hypoechoic portion of the tumor (Fig. 2b).
The finding of the contrast enhanced ultrasound of the
hyperechoic part of the tumor was in line with a classic
angiomyolipoma whereas the dignity of the hypoechoic
part remained unclear. A target biopsy of both parts was
performed. The histological examination showed a classic
angiomyolipoma in the biopsy specimen of the outer rim
(Fig. 3a) and an epithelioid angiomyolipoma in the biopsy
specimen of the center part (Fig. 3b). Immunohistochem-
istry showed strong positivity for melanocytic markers
and smooth muscle markers, confirming the diagnosis of
epithelioid angiomyolipoma. A subsequent nephrectomy
was performed confirming the diagnosis.
Discussion and conclusions
The incidence of occasional detection of renal masses
has increased with the wider application of various
Fig. 1 a Computer tomography scan without contrast material in 2008 displaying a solid mass close to the right kidney sinus of 2.81 × 2.34 cm in
diameters. b Computer tomography scan with contrast material in 2008 displaying an early enhancement of tumor ventral margin in the arterial phase
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imaging modalities [13, 14]. The individual imaging
methods alone can often not determine the dignity of
kidney tumors. The majority of benign kidney tumors
consist of oncocytomas and angiomyolipomas [15]. Be-
nign tumors do not require intervention unless they
cause the patient discomfort. The usual or classic angio-
myolipoma is relatively easily identified by applying
current imaging modalities. The high fat content in clas-
sic angiomyolipomas causes the tumors to appear very
echogenic in the B-mode of ultrasound and in computed
tomography an intensity of − 20 Hounsfield units is re-
corded. In our case, a differential diagnosis of atypical
sinus lipomatosis, lipoma and a transitional cell
carcinoma was postulated whereas based on a subse-
quent computed tomography a classic angiomyolipoma
was postulated.
However, a re-examination by contrast enhanced
ultrasound revealed a striking perfusion difference of the
hypoechoic and hyperechoic areas. Prior studies suggest
that contrast-enhanced ultrasound is a valuable method
in distinguishing angiomyolipoma from renal cell carcin-
oma [7, 16–18]. The outer rim of the renal mass de-
scribed in our patient displayed the classical features of
an angiomyolipoma: negative attenuation on the com-
puter tomography scan, hyperechoic appearance on the
B-Mode and homogenous and prolonged enhancement
Fig. 2 a B-mode ultrasound reveals two areas with different echogenicity within the tumor: Outer rim is hyperechoic with an echogenicity tumor to
normal kidney cortex ratio (TQ) of 2.27 (a value larger than 2.0 is characteristic for angiomyolipoma) and an inner hypoechoic portion (TQ 0.47) [11]. b Time
intensity curves (TIC) of the contrast enhanced ultrasound (CEUS) showing an early and strong enhancement of the hyperechoic outer rim (yellow line),
similar to renal cortex (blue line), and a later and weaker enhancement of hypoechoic inner portion (red line). The strong enhancement of the outer tumor
rim is clearly seen on the ventral side
Fig. 3 a Histology of the biopsy specimen taken from the hyperechoic tumor rim showing many vessels and fatty tissue confirming the diagnosis of
angiomyolipoma. b Histology of the biopsy specimen taken from the inner hypoechoic tumor showing pleomorphic multinucleated giant cells and
cells with predominant eosinophilic cytoplasm revealing an epithelioid variant of an angiomyolipoma
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of the ultrasound contrast agent. Classic angiomyolipo-
mas are composed of fat, smooth muscle cells and dys-
morphic vessels and thus the ultrasound contrast agent,
which does not trespass the vessels, enhanced this part
of the tumor rapidly and homogenously. The inner por-
tion of the renal mass was hypoechoic and showed a low
enhanced by the ultrasound contrast material due to the
absence of fat and a considerable low number of vessels
as shown by the histological analysis. Epithelioid variant
of angiomyolipoma (epithelioid angiomyolipoma) is a
rare tumor defined as a potentially malignant mesenchy-
mal neoplasm that has been described first by
Martignoni as a distinct variant of angiomyolipoma [19].
Epithelioid angiomyolipoma is characterized by the pres-
ence of plump and spindled epithelioid cells with varying
degrees of nuclear atypia and pleomorphic multinucle-
ated cells are often also present [1, 20]. According to the
current WHO classification, tumors with 80% and more
epithelioid cells are considered epithelioid angiomyoli-
poma [21]. Kidney epithelioid angiomyolipoma have
been reported often as a single case or small case series
of 20 to 41 patients and although solid evidence of the
dignity is spare, epithelioid angiomyolipoma are consid-
ered as a malignant neoplasm [22–27].
Our case for the first time displays the perfusion pat-
tern assessed by contrast enhanced ultrasound of classic
angiomyolipoma and epithelioid angiomyolipoma in a
single solid renal mass. Two distinct areas of the tumor
were identified by contrast enhanced ultrasound: A
hyperechoic part with strong perfusion and a hypoechoic
part with weak perfusion and fast contrast material wash
out. The result of the targeted biopsy revealed the diag-
nosis of an epithelioid angiomyolipoma embedded
within a classic angiomyolipoma. A nephrectomy was
performed because of the malignant potential of the epi-
thelioid variant of the angiomyolipoma. In prior reported
cases, diagnosis was made often after tumor resection or
in removed kidneys. Resection of angiomyolipoma is
considered when the tumor diameter exceeds 4 cm or
hemorrhage has occurred [28–30], although potential
life threatening bleeding has been reported to occur also
at lower diameter [31].
Epithelioid angiomyolipoma can pose diagnostic chal-
lenges [32–34]. Indeed, our report of a 51-year-old male
patient with a solid mass close to the right renal pelvis
demonstrates that a combination of different imaging
modalities including a diligent contrast enhanced ultra-
sound imaging studies with ultrasound-guided target bi-
opsies enabled diagnosis making and treatment.
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